KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Xenon Pharmaceuticals (XENE) Revenue: 2013-2025

Historic Revenue for Xenon Pharmaceuticals (XENE) over the last 9 years, with Mar 2025 value amounting to $7.5 million.

  • Xenon Pharmaceuticals' Revenue was N/A to $7.5 million in Q1 2025 from the same period last year, while for Mar 2025 it was $16.9 million, marking a year-over-year change of. This contributed to the annual value of $9.4 million for FY2022, which is 48.83% down from last year.
  • As of Q1 2025, Xenon Pharmaceuticals' Revenue stood at $7.5 million, which was up 5,581.82% from $132,000 recorded in Q3 2022.
  • Over the past 5 years, Xenon Pharmaceuticals' Revenue peaked at $8.8 million during Q1 2022, and registered a low of $132,000 during Q3 2022.
  • Moreover, its 1-year median value for Revenue was $7.5 million (2025), whereas its average is $7.5 million.
  • The largest annual percentage gain for Xenon Pharmaceuticals' Revenue in the last 5 years was 101.15% (2022), contrasted with its biggest fall of 97.07% (2022).
  • Over the past 3 years, Xenon Pharmaceuticals' Revenue (Quarterly) stood at $3.7 million in 2021, then crashed by 97.07% to $132,000 in 2022, then reached $7.5 million in 2025.
  • Its Revenue stands at $7.5 million for Q1 2025, versus $132,000 for Q3 2022 and $536,000 for Q2 2022.